European Union · Question · QUESTION_WRITTEN
E-9-2023-000069
Transparency of the European Medicines Agency and the case of Aplidin
Introduced
11 January 2023
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
10 March 2023
Records
Official question E-9-2023-000069 from European Union at European Parliament. Dated 11 January 2023. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Transparency of the European Medicines Agency and the Aplidin case
Transparency of the European Medicines Agency and the Aplidin case
QUESTION_WRITTEN · EN · 17 January 2023
Transparency of the European Medicines Agency and the Aplidin case
QUESTION_WRITTEN · EN · 17 January 2023
Transparency of the European Medicines Agency and the Aplidin case
QUESTION_WRITTEN · EN · 17 January 2023
Answer
QUESTION_WRITTEN_ANSWER · 10 March 2023
Transparencia de la Agencia Europea de Medicamentos y el caso del Aplidin
QUESTION_WRITTEN · ES · 17 January 2023
Transparencia de la Agencia Europea de Medicamentos y el caso del Aplidin
QUESTION_WRITTEN · ES · 17 January 2023
Transparencia de la Agencia Europea de Medicamentos y el caso del Aplidin
QUESTION_WRITTEN · ES · 17 January 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.